Tasman Therapeutics to Participate in Needham Virtual Psychedelics Forum on April 27, 2026
PRNewsWire
·
2026-04-23
·
via The Tech Buzz - Press Releases
SAN FRANCISCO, April 22, 2026 /PRNewswire/ -- Tasman Therapeutics, a biotechnology company developing novel treatments for patients with hard-to-treat mood disorders, announced today that CEO Dan Brow
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。